Application | Comment | Organism |
---|---|---|
pharmacology | enzyme IRAP is a therapeutic target for the treatment of limbic seizures | Rattus norvegicus |
Protein Variants | Comment | Organism |
---|---|---|
additional information | downregulation of enzyme IRAP by shRNA | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
angiotensin IV | IRAP ligands are on the one hand competitive inhibitors of the enzymatic activity of IRAP and on the other hand regulators of its trafficking | Rattus norvegicus | |
LVV hemorphin 7 | LVV-H7, IRAP ligands are on the one hand competitive inhibitors of the enzymatic activity of IRAP and on the other hand regulators of its trafficking | Rattus norvegicus |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
additional information | at the cellular level, IRAP immunoreactivity in neurons is associated with the trans-Golgi apparatus and vesicular structures in the proximity of the Golgi cisternae | Rattus norvegicus | - |
- |
plasma membrane | - |
Rattus norvegicus | 5886 | - |
vesicle | - |
Rattus norvegicus | 31982 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | P97629 | - |
- |
Rattus norvegicus Wistar | P97629 | - |
- |
Purification (Comment) | Organism |
---|---|
native enzyme in subcellular fractions | Rattus norvegicus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Rattus norvegicus | - |
embryo | - |
Rattus norvegicus | - |
hippocampus | - |
Rattus norvegicus | - |
additional information | enzyme IRAP is highly expressed in brain areas associated with cognition and epilepsy, regions that also display the highest densities of sst2A receptor immunoreactivity. Immunohistochemic analysis, quantitative analysis of immunofluorescence | Rattus norvegicus | - |
neuron | embryonic hippocampal neurons, tissue culture | Rattus norvegicus | - |
Synonyms | Comment | Organism |
---|---|---|
insulin-regulated aminopeptidase | - |
Rattus norvegicus |
IRAP | - |
Rattus norvegicus |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Rattus norvegicus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.4 | - |
assay at | Rattus norvegicus |
General Information | Comment | Organism |
---|---|---|
physiological function | the insulin-regulated aminopeptidase (IRAP) is involved in vesicular trafficking and shares common regional distribution with the major somatostatin (SRIF) receptor subtype, the sst2A receptor, which is localized at postsynaptic sites of the principal neurons where it modulates neuronal activity. IRAP regulates the trafficking of the sst2A receptor, it is a negative regulator of sst2A receptor recycling. Following agonist exposure, this receptor rapidly internalizes and recycles slowly through the trans-Golgi network. IRAP ligands display anticonvulsive properties involving the sst2A receptor. IRAP ligands accelerate the recycling of the sst2A receptor that has internalized in neurons in vitro or in vivo. Most importantly, because IRAP ligands increase the density of this inhibitory receptor at the plasma membrane, they also potentiate the neuropeptide SRIF inhibitory effects on seizure activity. In addition to its aminopeptidase activity involved in peptide hormone processing, IRAP also acts as a receptor for the endogenous ligands angiotensin IV (Ang IV) and LVV hemorphin 7 (LVV-H7). IRAP ligands are on the one hand competitive inhibitors of the enzymatic activity of IRAP and on the other hand regulators of its trafficking with memory- and cognitive-enhancing effects of IRAP ligands. The extracellular part of IRAP contains the aminopeptidase activity, whereas its intracellular domain interacts with cytosolic proteins that contribute to GLUT4 vesicle retention and translocation to the plasma membrane | Rattus norvegicus |